AUTM Technology Valuation Course Agenda

AbbvieLilly
AUTM Annual Meeting

AUTM Technology Valuation Course Agenda

Sunday, March 8
7:30 a.m. – 4 p.m.
 
 

Sunday, March 8

7:30 a.m. Welcome and Introduction
7:30 – 7:50 a.m. Creating Value

This session is a continuation of the webinar discussion on creating value, which provided students with an understanding of the licensee's business model and key success factors, the importance of the licensed intellectual property (IP) in generating value, and how these affect license terms and negotiation.

Instructor                           
Michael Sharer
7:50 – 9:05 a.m. Measuring Value

This session is a continuation of the webinar discussion on measuring value, which will examine the key accounting assumptions, the measures and projections that quantify the financial performance of the licensee and how these are used to determine the commercial terms of the license.

Instructors
Andrew Maas, Louisiana State University
Debbie Stewart, Invotex IP
Steve Ferguson, National Institutes of Health

9:05 – 9:20 a.m. 

Sharing Value
This session is a continuation of the webinar discussion on sharing value, which will examine the key mechanisms used to share value between the licensee and the licensor.

Instructor
Steve Ferguson,

9:20 – 9:35 a.m. Morning Break
9:35 – 10:15 a.m. 

Sharing Value (Continued)

Instructor
Ashley Stevens, Focus IP Group, LLC

10:15 – 11:05 a.m. 

Start-ups
This session is a continuation of the webinar discussion on start-ups, we will explore the different issues specific to licensing start-ups, such as taking on equity as partial consideration for the license and much more.

Instructors                           
Andrew Maas, Louisiana State University
Ashley Stevens, Focus IP Group, LLC

11:05 – 11:45 a.m.  Case Study Discussions
11:45 a.m. – 12:45 p.m. Lunch
12:45 – 3 p.m. Case Study Discussions (Continued)
3 – 3:15 p.m. Afternoon Break
3:15 – 3:50 p.m. Case Study Discussions (continued)
3:50 – 4 p.m. Wrap-up Discussions and Questions
4 p.m.     Course Adjourns


Annual Meeting Sponsors

AstraZeneca
Elanco Animal Health
Osage University Partners
Amster, Rothstein & Ebenstein LLP
NIIMBL
Burford Capital
Merck
Parker Highlander PLLC
Boehringer Ingelheim Pharmaceuticals Inc.
Marshall Gerstein
Michael Best & Friedrich
LifeArc
Polsinelli PC
Bereskin & Parr LLP
Novartis Institutes for BioMedical Research
Oblon
Hamilton Brook Smith Reynolds
Eli Lilly and Company
BCC Research
AbbVie
Schwegman Lundberg & Woessner
Blank Rome LLP
MPEG LA LLC
Baker Donelson
Casimir Jones, SC
Royalty Pharma
Smith, Gambrell & Russell
Pabst Patent Group LLP
CrossPond Law
Quarles & Brady LLP
Hodgson Russ LLP
Wellspring
TreMonti Consulting LLC